To successfully move your product through the preclinical and clinical stages of development, a sound and clear approach is of utmost importance. We provide strategic advice on regulatory requirements for the nonclinical program and the early clinical strategy for your product. We will help you to design and execute your IND enabling studies, which includes the selection of the appropriate CRO, design of the key experiments, coordination of the study conduct and evaluation of the final data. We provide the nonclinical documentations and support for regulatory agency meetings globally.